Cargando…

Screening for Diabetic Retinopathy with Extended Intervals, Safe and Without Compromising Adherence: A Retrospective Cohort Study

INTRODUCTION: Screening for diabetic retinopathy (DR) prevents blindness through the early detection of sight-threatening retinal microvascular lesions that respond to timely local treatment. However, the provision of easy and regular access to DR screening programs is currently being challenged by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharif, Ali, Jendle, Johan, Hellgren, Karl-Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649703/ https://www.ncbi.nlm.nih.gov/pubmed/33165837 http://dx.doi.org/10.1007/s13300-020-00957-0

Ejemplares similares

Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme
por: Looker, H. C., et al.
Publicado: (2013)

Can the Retinal Screening Interval Be Safely Increased to 2 Years for Type 2 Diabetic Patients Without Retinopathy?
por: Chalk, Daniel, et al.
Publicado: (2012)

Extending the diabetic retinopathy screening interval beyond 1 year: systematic review
por: Taylor-Phillips, Sian, et al.
Publicado: (2016)

Screening Intervals for Diabetic Retinopathy and Implications for Care
por: Scanlon, Peter H.
Publicado: (2017)

Mastering Rust: write safe, concurrent and reliable programs without compromising on performance
por: Kaihlavirta, Vesa
Publicado: (2017)

A ‘Fail-Safe’ Screening Programme for Diabetic Retinopathy
por: Ryder, R E J, et al.
Publicado: (1998)

hTERT Extends the Life of Human Fibroblasts without Compromising Type I Interferon Signaling
por: Smith, Miles C., et al.
Publicado: (2013)

Sleeping Safely! A Quality Improvement Project to Minimize Nighttime Interruptions without Compromising Patient Care
por: Lee, Clifton C., et al.
Publicado: (2021)

Testing key messages about extending cervical screening intervals
por: A.V. Marlow, Laura, et al.
Publicado: (2022)

Investigation of extended blinks and interblink intervals in subjects with and without dry eye
por: Rodriguez, John D, et al.
Publicado: (2013)

Adopting 3-Year Screening Intervals for Sight-Threatening Retinal Vascular Lesions in Type 2 Diabetic Subjects Without Retinopathy
por: Agardh, Elisabet, et al.
Publicado: (2011)

Barriers for Adherence to Diabetic Retinopathy Screening among Saudi Adults
por: Alwazae, Manal, et al.
Publicado: (2019)

Correlates of women’s intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval
por: Ogilvie, Gina S., et al.
Publicado: (2016)

Limited Retinacular Vessel Damage Does Not Compromise Femoral Head Perfusion During Hip Arthroscopy - Can the Vascular Safe Zone be Extended?
por: Nawabi, Danyal H., et al.
Publicado: (2015)

Carbohydrate Loading Followed by High Carbohydrate Intake During Prolonged Physical Exercise and Its Impact on Glucose Control in Individuals With Diabetes Type 1—An Exploratory Study
por: Mattsson, Stig, et al.
Publicado: (2019)

Editorial: Physical Activity and Type 1 Diabetes
por: Jendle, Johan H., et al.
Publicado: (2019)

Can a Risk Factor Based Approach Safely Reduce Screening for Retinopathy of Prematurity?
por: Friddle, K. M., et al.
Publicado: (2017)

Nothing is safe: Intolerance of uncertainty is associated with compromised fear extinction learning
por: Morriss, Jayne, et al.
Publicado: (2016)

Lamotrigine extends lifespan but compromises health span in Drosophila melanogaster
por: Avanesian, Agnesa, et al.
Publicado: (2009)

Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence
por: Osmani, Zgjim, et al.
Publicado: (2021)

FRI640 Adherence To Diabetic Retinopathy Screening Guidelines In An Adolescent Patient Population
por: Sami, Asra, et al.
Publicado: (2023)

Epigenetic Modifications Compromise Mitochondrial DNA Quality Control in the Development of Diabetic Retinopathy
por: Mohammad, Ghulam, et al.
Publicado: (2019)

Identifying genetic relatives without compromising privacy
por: He, Dan, et al.
Publicado: (2014)

Skin Cleansing without or with Compromise: Soaps and Syndets
por: Mijaljica, Dalibor, et al.
Publicado: (2022)

Extending screening intervals for women at low risk of breast cancer: do they find it acceptable?
por: McWilliams, Lorna, et al.
Publicado: (2021)

Real-World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort
por: Pelle, Juliette, et al.
Publicado: (2023)

Is prilocaine safe and potent enough for use in the oral surgery of medically compromised patients
por: Gazal, Giath
Publicado: (2019)

Maximising the acceptability of extended time intervals between screens in the NHS Cervical Screening Programme: An online experimental study
por: Hill, Emily, et al.
Publicado: (2020)

Retrospective Cohort Analysis of the Effect of Antimicrobial Stewardship on Postoperative Antibiotic Therapy in Complicated Intra-Abdominal Infections: Short-Course Therapy Does Not Compromise Patients’ Safety
por: Surat, Güzin, et al.
Publicado: (2022)

Effects on body weight, eating behavior, and quality of life of a low‐energy diet combined with behavioral group treatment of persons with class II or III obesity: A 2‐year pilot study
por: Karlsson, Jan, et al.
Publicado: (2020)

A cluster randomized controlled trial of extending ART refill intervals to six-monthly for anti-retroviral adherence clubs
por: Wilkinson, Lynne, et al.
Publicado: (2019)

Improved Porosity of Insect Proof Screens Enhances Quality Aspects of Zucchini Squash without Compromising the Yield
por: Formisano, Luigi, et al.
Publicado: (2020)

Structural impact of arrested foveal development in children born extremely preterm without ROP at 6.5 years of age
por: Venkataraman, Abinaya Priya, et al.
Publicado: (2022)

“A lot can happen in five years”: Women's attitudes to extending cervical screening intervals
por: Kola‐Palmer, Susanna, et al.
Publicado: (2022)

Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study
por: Cantini, Luca, et al.
Publicado: (2023)

Individualised risk assessment for diabetic retinopathy and optimisation of screening intervals: a scientific approach to reducing healthcare costs
por: Lund, S H, et al.
Publicado: (2016)

The prevalence and risk factors of diabetic retinopathy in selected primary care centers during the 3-year screening intervals
por: Magliah, Sultan F., et al.
Publicado: (2018)

Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine
por: Eleuteri, Antonio, et al.
Publicado: (2017)

Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial
por: Scherbak, Nikolai N., et al.
Publicado: (2023)

Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial (Diabetes Metab J 2023;47:668-81)
por: Scherbak, Nikolai N., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hqpucornvv4s7v0m6j3pkd69m3